Keyphrases
Hazard Ratio
100%
Positron Emission Tomography
100%
Risk Stratification
100%
Functional Imaging
100%
Peripheral T-cell Lymphoma
100%
Event-free Survival
75%
Overall Survival
50%
Metabolic Tumor Volume
37%
Confidence Interval
25%
Multivariate Analysis
25%
International Prognostic Index
25%
Interim PET
25%
Risk-adapted Treatment
25%
Prednisone
12%
Median Overall Survival
12%
Univariate Analysis
12%
Standardized Uptake Value
12%
Autologous Transplantation
12%
Clinical Parameters
12%
Imaging Characteristics
12%
Treatment Paradigms
12%
Doxorubicin
12%
Prognostic Score
12%
Cyclophosphamide
12%
Tomography Image
12%
4-cycle
12%
Point Score
12%
Interim Positron Emission Tomography
12%
Medicine and Dentistry
Positron Emission Tomography
100%
Hazard Ratio
100%
Peripheral T-Cell Lymphoma
100%
Functional Imaging
100%
Event Free Survival
75%
Overall Survival
62%
Neoplasm
37%
Multivariate Analysis
25%
International Prognostic Index
25%
CHOP
25%
Polyethylene Terephthalate
25%
Transplantation
12%
Prospective Study
12%
Univariate Analysis
12%
Standardized Uptake Value
12%
Doxorubicin
12%
Cyclophosphamide
12%
Prednisone
12%
Vincristine
12%
Neuroscience
Positron Emission Tomography
100%
Functional Imaging
100%
T Cell
100%
Positron Emission Tomography
50%
CHOP
50%
Cyclophosphamide
25%
Vincristine
25%
Prednisone
25%
Doxorubicin
25%
Psychology
Positron-Emission Tomography
100%
Functional Imaging
100%
Hazard Ratio
100%
Multivariate Analysis
25%
Univariate Statistics
12%
Veterinary Science and Veterinary Medicine
T-Cell Lymphoma
100%
Neoplasm
75%
Prednisone
25%
Doxorubicin
25%